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Abstract
There is currently a dearth of appropriate methods to estimate the causal effects of
multiple treatments when the outcome is binary. For such settings, we propose the use
of nonparametric Bayesian modeling, Bayesian Additive Regression Trees (BART). We
conduct an extensive simulation study to compare BART to several existing, propen-
sity score-based methods and to identify its operating characteristics when estimating
average treatment effects on the treated. BART consistently demonstrates low bias
and mean-squared errors. We illustrate the use of BART through a comparative effec-
tiveness analysis of a large dataset, drawn from the latest SEER-Medicare linkage, on
patients who were operated via robotic-assisted surgery, video-assisted thoratic surgery
or open thoracotomy.
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1 Introduction
1.1 Motivating Research Question
Lung cancer is the leading cause of cancer-related mortality worldwide and is estimated to
cause over 1.7 million deaths in 2018 (Ferlay et al., 2018). The most common type of lung
cancer is non-small cell lung cancer (NSCLC), accounting for approximately 85% of all lung
cancer cases (Molina et al., 2008). When feasible, NSCLC tumors are treated using surgical
resection, which remains the single most consistent option for a cure (Uramoto and Tanaka,
2014).
Open thoracotomy long stood as the standard surgical procedure for stage I-IIIA NSCLC
tumors. However, open thoracotomy is associated with considerable postoperative compli-
cations and mortality, especially in the elderly (Scott et al., 2010; Whitson et al., 2008).
Beginning in the late 1990?s, two newer and less invasive techniques, video-assisted thoratic
surgery (VATS) and robotic-assisted surgery, were increasingly recommended by national
guidelines (Park et al., 2012; Wisnivesky et al., 2011). The adoption of VATS and robotic-
assisted surgery seemed to signal that the newer procedures offer a clinical benefit relative to
open resection (Yan et al., 2009; Toker, 2014). However, to our knowledge, no randomized
controlled trials (RCTs) have been conducted to compare the effectiveness of these surgical
procedures, in part due to difficulties in recruiting patients and to high study costs. As a
consequence, VATS and robotic-approaches were adopted into routine care without sufficient
scrutiny (Park et al., 2012; Cajipe et al., 2012).
In place of RCTs, large-scale population-based databases, such as the Surveillance, Epi-
demiology, and End Results (SEER)-Medicare database that includes demographic and clin-
ical information for Medicare beneficiaries with cancer in various United States regions (War-
ren et al., 2002), can be used to compare the effectiveness of these surgical procedures. The
SEER-Medicare database comprises a valid and large sample of patients who received each
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of the three surgical procedures and reflects patient behavior in a real world setting. How-
ever, in contrast to RCTs, the real-world adoption pattern of robotic-assisted surgery, VATS,
or open thoracotomy largely depends on the patients’ sociodemographic characteristics and
clinical conditions, which may result in a unbalanced cohort with significant differences in
the distributions of sociodemographic characteristics, comorbidities, cancer characteristics
and diagnostic information across treatment groups (Veluswamy et al., 2017).
One way to account for such underlying differences in patient characteristics would be
to compare each pair of surgical procedures using statistical methods designed for a binary
treatment (Wisnivesky et al., 2010; Cajipe et al., 2012; Park et al., 2012). Unfortunately,
applications of these methods can lead to the comparisons of disparate patient subgroups,
which may increase bias in treatment effect estimates (Lopez et al., 2017). Additionally,
results built from pairwise binary comparisons are not suitable for identifying the optimal
treatment when there are more than two treatment options available (Lopez et al., 2017).
1.2 Statistical Methods for Causal Inference with Multiple Treat-
ments
Recent years have seen a growing interest in the development of causal inference methods
with multiple treatments using observational data. The theoretical work of Imbens (2000)
and Imai and Van Dyk (2004) extended the propensity score framework in the setting with
a binary treatment (Rosenbaum and Rubin, 1983) to the general treatment setting. Subse-
quently, methods designed for a binary treatment have been reformulated to accommodate
multiple treatments, including regression adjustment (Linden et al., 2016), inverse probabil-
ity of treatment weighting (Feng et al., 2012; McCaffrey et al., 2013), vector matching (Lopez
et al., 2017), and subclassification (Zanutto et al., 2005). Lopez et al. (2017) provides a com-
prehensive review of current methods for multiple treatments, and a unified terminology that
enables researchers to compare existing methods.
While advanced propensity score based techniques are recently feasible with multiple
treatments, the supply of these methods does not match the demand from researchers or the
complexity of patient-centered outcomes research. Outcomes of interest in patient centered
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outcomes research are often dichotomous. For example, postoperative complications and
mortality are outcomes of interest among cancer patients. With binary outcomes, common
estimands to quantify the effect of a treatment include the risk difference (RD), odds ratio
(OR), and relative risk (RR) (Agresti, 2003). The choice of which estimand to report should
be based on scientific judgment (Nurminen, 1995). Different causal estimands for binary
outcomes require modifications of the existing propensity-based methods reformulated for
multiple treatments. However, it is unclear how these methods extend to binary outcomes,
and also difficult to obtain coherent interval estimates as there is lack of a uniform approach
for variance estimation, especially for matching and subclassification (Imbens, 2004; Hill,
2011).
1.3 Bayesian Additive Regression Trees for Causal Inference
In recent years, nonparametric modeling of the response surface – a model for the potential
outcomes conditioning on the treatment and confounding variables – has gained traction
as an alternative to propensity score based methods that require creating a well-balanced
cohort (Hahn, 1998; Hill, 2011; Wager and Athey, 2018). These nonparametic estimation
methods do not make strict parametric assumptions and are robust to misspecification of
the response surface model.
Hill (2011) proposed the use of nonparametric Bayesian modeling, Bayesian Additive Re-
gression Trees (BART) (Chipman et al., 2010), for causal inference with a binary treatment
and a continuous outcome. Hill (2011) and Hill and Su (2013) used simulations to show that,
in scenarios where there are nonlinearities in the response surface and/or the treatment as-
signment mechanism, BART generates more accurate estimates of average treatment effects
compared to various matching and weighting techniques, and comparable estimates in linear
settings.
BART boasts several advantages when adapted into causal inference with a binary treat-
ment (Hill, 2011; Dorie et al., 2016). First, BART can flexibly model nonlinear response
surfaces. Second, BART bypasses the complexity of propensity score model implementation
and avoids ambiguity with respect to balance diagnostics. Third, BART can handle a large
number of both continuous and discrete pre-treatment covariates. Fourth, in simulations
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with a binary treatment, BART generated treatment effect estimates that were less biased
and with lower mean square error (MSE). Fifth, BART generates coherent uncertainty in-
tervals, which can be interpreted as posterior credible intervals from a Bayesian perspective.
Sixth, with binary outcomes, BART can calculate estimands such as odds ratio and relative
risk that are often of clinical interest. Finally, BART is accessible to applied researchers and
requires less researcher programming expertise.
We surmise that the strengths of BART are transferable to the multiple treatment setting.
In this paper, we investigate the operating characteristics of BART for estimating causal
effects with multiple treatments and a binary outcome. We compare BART to existing
methods, including regression adjustment (Linden et al., 2016), inverse probability weighting
(Feng et al., 2012), and vector matching (Lopez et al., 2017), for estimating the causal
effects of multiple treatments with a binary outcome via an extensive simulation study.
For all of the estimands considered and in most of scenarios that were examined, BART
yields treatments effects with the lowest biases and mean-squared errors. We subsequently
apply BART to analyze a large dataset drawn from the latest SEER-Medicare linkage, which
includes patients ≥65 years of age with stage I-IIIA NSCLC who were diagnosed between
2008 and 2013, and treated with surgical resection via robotic-assisted surgery, VATS or
open thoracotomy.
This paper is organized as follows: Section 2 describes the potential outcomes framework
for multiple treatments. Section 3 reviews the existing methods to estimate causal effects
with multiple treatments. Section 4 presents the use of BART to estimate causal effects in
the multiple treatments setting. Section 5 details the design and results of the Monte Carlo
Simulation. Section 6 illustrates the use of BART through a causal comparative effectiveness
analysis that examines three surgical approaches for patients with NSCLC. Conclusions and
discussions are provided in Section 7. Simulation code and a walk-through example using
BART are provided at (site available upon publication).
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2 Potential Outcomes Framework for Multiple Treat-
ments
2.1 Notation
Our notation is based on the potential outcomes framework, which was originally proposed
by Neyman (1923) in the context of randomization-based inference in experiments. Potential
outcomes were generalized to observational studies and Bayesian analysis by Rubin (1974,
1977, 1978), in what is now known as the Rubin Causal Model (RCM) (Holland, 1986).
Consider a sample of N units, indexed by i = 1, . . . , N , drawn randomly from a target
population, which comprises the individuals in a study designed to evaluate the effect of
a treatment or exposure W on some outcome Y . Each unit is exposed to one of total Z
possible treatments; that is, Wi = w if individual i was observed under treatment w, where
w ∈ W = {w1, w2, . . . , wZ}. The number of units receiving treatment w is Nw, where∑Z
1 Nw = N . For each unit i, there is a vector of pre-treatment covariates, Xi, that are
not affected by W . Assuming the stable unit treatment value assumption (SUTVA) (Rubin,
1980), that is, no interference between units and no different versions of a treatment, the
observable outcome, Yi, for unit i can be written as
Yi =
∑
w∈{w1,w2,...,wZ}
Yi(w)I(Wi = w), (1)
where I(·) is an indicator function. For each unit, at most one of the potential outcomes
is observed (the one corresponding to the treatment to which the unit is exposed). All
other potential outcomes are missing, which is known as the fundamental problem of causal
inference (Holland, 1986).
2.2 Estimands
Causal effects are summarized by estimands, which are functions of the unit-level potential
outcomes on a common of set of units (Rubin, 1974, 1978). In this paper, with dichotomous
outcomes, we focus on causal risk differences. Following Lopez et al. (2017), we provide a
broad definition of the causal risk differences that may be of interest with multiple treatments.
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Define s1 and s2 as two subgroups of treatments such that s1, s2 ⊂ W and s1 ∩ s2 = ∅.
Next, let |s1| and |s2| be the cardinality of s1 and s2, respectively. Two commonly used
estimands are the super-population average treatment effect (PATE), PATEs1,s2 , and the
super-population average treatment effect among those receiving s1, PATTs1|s1,s2 , where
PATEs1,s2 = E
[∑
w∈s1 Yi(w)
|s1| −
∑
w′∈s2 Yi(w
′)
|s2|
]
,
PATTs1|s1,s2 = E
[∑
w∈s1 Yi(w)
|s1| −
∑
w′∈s2 Yi(w
′)
|s2|
∣∣∣∣Wi ∈ s1]. (2)
In (2), the expectation is over all units, i = 1, . . . , N , and the summation is over the potential
outcomes of a specific unit.
The finite-sample version of average treatment effects are also defined,
SATEs1,s2 = N
−1
N∑
i=1
[∑
w∈s1 Yi(w)
|s1| −
∑
w′∈s2 Yi(w
′)
|s2|
]
,
SATTs1|s1,s2 = (
∑
w∈s1
Nw)
−1 ∑
i:Wi∈s1
[∑
w∈s1 Yi(w)
|s1| −
∑
w′∈s2 Yi(w
′)
|s2|
∣∣∣∣Wi ∈ s1].
(3)
A third pair of target estimands is the treatment effect, conditioning on covariate x,
PATEs1,s2(x) = E
[∑
w∈s1 Yi(w)
|s1| −
∑
w′∈s2 Yi(w
′)
|s2|
∣∣∣∣Xi = x; θY |X]
PATTs1|s1,s2(x) = E
[∑
w∈s1 Yi(w)
|s1| −
∑
w′∈s2 Yi(w
′)
|s2|
∣∣∣∣Wi ∈ s1,Xi = x; θY |X] (4)
where the parameters θY |X and θX index the conditional distribution p(Y |X) and distribution
p(X), respectively.
Causal inference methods via modeling the response surfaces arrive at the population or
sample marginal treatment effects by integrating the conditional effects over the distribution
of x (Ding and Li, 2017). In most cases, however, it is difficult to model the possibly multi-
dimensional pre-treatment covariates Xi. We can obtain the marginal effects by averaging
the treatment effects conditional on the observed values of the covariates over the empirical
distribution of {Xi}Ni=1,
PATEs1,s2 =
∫
PATEs1,s2(x, θY |X)dFX(x; θX)
PATTs1|s1,s2 =
∫
PATTs1|s1,s2(x, θY |X)dFX(x; θX),
(5)
In our motivating example, we are particularly interested in comparing the effectiveness of
a newer minimally-invasive procedure, robotic-assisted surgery, versus the existing surgical
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procedures, VATS and open thoracotomy, on those who received robotic-assisted surgery.
Hence, Z = 3 and |s1| = |s2| = |s3| = 1. Our target causal estimands are
ATTs1|s1,s2 =
∫
[(
∑
w∈s1
Nw)
−1 ∑
i:Wi∈s1
{Yi(w)− Yi(w′)|w ∈ s1, w′ ∈ s2,Xi, θY |X}]dFX(x; θX),
ATTs1|s1,s3 =
∫
[(
∑
w∈s1
Nw)
−1 ∑
i:Wi∈s1
{Yi(w)− Yi(w′)|w ∈ s1, w′ ∈ s3,Xi, θY |X}]dFX(x; θX).
(6)
2.3 Assumptions
In general, causal effects are not identifiable without further assumptions because only one
of the potential outcomes is observed for every unit. The key assumptions concern the
assignment mechanism (Imbens and Rubin, 2015).
Assumption 1 An assignment mechanism is super-population probabilistic if
0 < p(w|Yi(w1), . . . , Yi(wZ),Xi) < 1, ∀ w ∈ {w1, . . . , wZ},
for each possible Yi(w1), . . . , Yi(wZ),Xi, i = 1, . . . , N .
Assumption 1 is also known as positivity or sufficient overlap assumption, which implies that
there are no values of pre-treatment covariates that could occur only among units receiving
one of the treatments.
Assumption 2 (Unconfoundedness) A super-population unconfounded assignment mech-
anism requires that
p(W = w|Yi(w1), . . . , Yi(wZ),Xi) = p(W = w|Xi), ∀ w ∈ {w1, . . . , wZ}.
Assumption 2 implies that the set of observed pre-treatment covariates, Xi, is sufficiently rich
such that it includes all variables directly influencing both Wi and Yi; in other words, there
is no unmeasured confounding. Assumption 2 cannot be empirically tested or validated.
Several additional pieces of notation will be useful in the remainder of the paper. First,
the generalized propensity score (GPS) is defined as r(w,x) = Pr(W = w|X = x), for
∀ w ∈ {w1, . . . , wZ} (Imbens, 2000; Imai and Van Dyk, 2004). This definition extends
the propensity score (Rosenbaum and Rubin, 1983) from a binary treatment setting to the
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multiple treatment setting, in which conditioning often must be done on a vector of GPS’s,
defined as R(x) = (r(w1,x), . . . , r(wZ ,x)), or a function of R(x) (Imai and Van Dyk, 2004).
Also, for w ∈ {w1, . . . , wZ}, the response surface is defined as
f(w,x) ≡ E[Y (w)|X = x]. (7)
Under Assumption 2, the response surface satisfies that for any w, w′, x
f(w,x) = E[Y (w)|W = w,X = x] = E[Y |W = w,X = x], (8)
where the first identity is the about the counterfactual mean if w 6= w′ and the second
identity is the conditional mean function of the observed outcomes.
3 Current Approaches for Multiple Treatments
In this section, we briefly describe existing methods to estimate causal effects with multiple
treatments, which are valid under Assumptions 1 and 2.
3.1 Regression Adjustment
A common approach for causal inference in observational studies is regression adjustment
(RA) (Rubin, 1973, 1979), also known as model-based imputation (Imbens and Rubin, 2015).
RA uses a regression model to impute missing outcomes, estimating what would have hap-
pened to a specific unit had this unit been subject to the treatment to which it was not
exposed. As a result of the fundamental problem of causal inference (Holland, 1986), there
is an intrinsic connection between causal inference methods and missing data analysis, and
all methods for causal inference can be at some level viewed as imputation methods (Imbens
and Rubin, 2015; Ding and Li, 2017).
More specifically, we first fit a Bayesian logistic regression model on a set of pre-treatment
covariates separately for each treatment level
f(w,xi) = E[Yi|Wi = w,Xi = xi] = logit−1{x′iβw}, i = 1, . . . , Nw, w ∈ {w1, w2, . . . , wZ}
(9)
where βw is a set of regression coefficients. Then a total of L Markov Chain Monte Carlo
(MCMC) samples of model parameters, βw, are drawn from its posterior distribution. For
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each of L draws, we predict the potential outcomes for each unit and the relevant treatment
level. Suppose that ATTw1,w2|w1 is the causal estimand of interest, which can be estimated
by contrasting the imputed potential outcomes between w1 and w2,
ÂTT
RA
w1,w2|w1 = (Nw1L)
−1
L∑
l=1
∑
i:i∈w1
{
f l(w1,xi)− f l(w2,xi)
}
= (Nw1L)
−1
L∑
l=1
∑
i:i∈w1
{
logit−1{x′iβlw1} − logit−1{x′iβlw2}
}
,
(10)
where βlw1 and β
l
w2
are the lth draw of regression parameters from their posterior distribu-
tions. When L > 100, we can obtain the point and interval estimates of treatment effects
directly using the summary of posterior samples, otherwise Rubin’s multiple imputation
combining rule (Rubin, 1987) can be used for inference.
The critical part of this method is the specification of the functional form of the regression
model. With a low-dimensional set of pre-treatment covariates, it is relatively easy to specify
a flexible functional form for the outcome model. If there are many covariates, however, such
a specification is more difficult, and possible misspecification of the regression function could
bias the treatment effect estimate. In addition, this method heavily relies on extrapolation
for estimation when the covariate distributions between treatment groups are substantially
far apart (Imbens and Rubin, 2015).
3.2 Inverse Probability of Treatment Weighting
Another widely used method for estimating causal effects with multiple treatments uses the
inverse probability of treatment assignment as weights (IPTW, (Imbens, 2000; Feng et al.,
2012; McCaffrey et al., 2013)). Weighing methods attempt to obtain an unbiased estimator
for average treatment effect in a way akin to the setting in which weighting by the inverse
of the selection probability adjust for unbalances in sampling pools, introduced by Horvitz
and Thompson (1952) in survey research. The weighting estimator of ATTw1,w2|w1 can be
written as follows:
ÂTT
IPTW
w1,w2|w1 = (Nw1)
−1
N∑
i=1
YiI(Wi = w1)− (Nw1)−1
N∑
i=1
YiI(Wi = w2)rˆ(w1,Xi)/rˆ(w2,Xi),
(11)
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where rˆ(w,Xi) is the estimated generalized propensity score (GPS) (Imbens, 2000). When
using IPTW, extreme weights that are close to 0 or 1 can yield erratic causal estimates with
large sample variances (Little, 1988; Kang et al., 2007). This issue is increasingly likely as Z
increases, where treatment assignment probabilities for some treatment may become quite
small (Lopez et al., 2017).
3.3 Vector Matching
Lopez et al. (2017) proposed the vector matching algorithm (VM), where the goal of VM
to find sets of subjects receiving different each w ∈ W such that p(W = w|Xi), ∀ w ∈
{w1, . . . , wZ} (e.g, they are matched on a vector of GPSs). VM obtains matched sets using
a combination of k-means clustering and one-to-one matching, steps designed to ensure that
the matched cohort is relatively similar in terms of the distributions of observed covariates.
If matched sets are obtained for all subjects in the study population receiving reference treat-
ment w, differences in observed outcomes among those matched reflect unbiased estimates
of the ATT s generalizable to those receiving w.
In simulations, VM outperformed bivariate approaches that used only one-to-one match-
ing on unique pairs of treatments w and w′, where w,w′ ∈ W and w 6= w′. Lopez et al.
(2017) also identified that VM compared favorably to IPTW for non-normal distributions
of X, with the two approaches roughly similar when X was not normal. In recent work,
Scotina and Gutman (2018a) expanded VM to cover fuzzy matching, while Scotina and
Gutman (2018b) summarized variance estimation using VM.
4 BART for Estimating Causal Effects of Multiple Treat-
ments
Under the unconfoundedness assumption, ATTw1,w2|w1 can be estimated by contrasting the
imputed potential outcomes between w1 and w2, predicted from the estimates of the response
surface f(w,x). In principle, any method that can flexibly estimate f(·) could be used to
predict the potential outcomes. Hill (2011) proposed the use of Bayesian Additive Regression
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Trees (BART) (Chipman et al., 2007, 2010) to assess the causal effects of a binary treatment
and a continuous outcome. Chipman et al. (2007, 2010) demonstrated that BART has
important advantages as a predictive algorithm over alternative methods in the machine
learning literature such as classification and regression trees (CART) methodology (Breiman
et al., 1984), boosting (Freund and Schapire, 1997) and random forests (Breiman, 2001), in
particular with regard to choosing tuning parameters and generating coherent uncertainty
intervals.
BART is a Bayesian ensemble method that models the mean outcome given predictors
by a sum of trees. For a binary outcome, the BART model can be expressed using the probit
model setup as:
f(wi,xi) = E(Yi|Wi = wi,Xi = xi) = Φ
{ J∑
j=1
gj(wi,xi;Tj,Mj)
}
, (12)
where Φ is the the standard normal c.d.f., each (Tj,Mj) denotes a single subtree model in
which Tj denotes the regression tree and Mj is a set of parameter values associated with
the terminal nodes of the jth regression tree, gj(wi,xi) represents the mean assigned to the
node in the jth regression tree associated with covariate value xi and treatment level wi,
and the number of regression trees J is considered to be fixed and known. The details of
the specification of prior distribution and the choice of hyper-parameters can be found in
Chipman et al. (2010). Sampling from the posterior distributions proceed via a Bayesian
backfitting MCMC algorithm Chipman et al. (2010).
Similar with the RA method in Section 3.1, ATTw1,w2|w1 can be estimated as follows:
ÂTT
BART
w1,w2|w1 = (Nw1L)
−1
L∑
l=1
∑
i:i∈w1
{
f l(w1,xi)− f l(w2,xi)
}
= (Nw1L)
−1
L∑
l=1
∑
i:i∈w1
{
Φ
[ J∑
j=1
gj(w1,xi;T
l
j ,M
l
j)
]
− Φ
[ J∑
j=1
gj(w2,xi;T
l
j ,M
l
j)
]}
,
(13)
where (T lj ,M
l
j) are the lth draw from the posterior distribution of (Tj,Mj). Inference can be
obtained following the same way as the RA method described in Section 3.1.
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5 Simulation
In this section, we follow the simulation design described in Hill and Su (2013) to explore
evidence regarding the performance of BART and alternatives methods described in Section 3
for estimation of causal effects with multiple treatments.
5.1 Simulation Design
The scenarios considered here use configurations build from six factors, each of which use
Z = 3 three treatment levels. The first factor is the ratio of units in three treatment groups,
that is, N1 : N2 : N3 = 4 : 2 : 1, 1 : 1 : 1, or 1 : 2 : 4, where N1, N2 and N3 are the number of
units in each of three treatment groups, respectively. The second factor is the total number
of units in three treatment groups, N ∈ {700, 3500}. The third factor is the number of
predictors available to the researcher, p ∈ {10, 50}, although in both cases not all predictors
are relevant to the treatment assignment mechanism and the response surface (see Table 1).
We assume that each covariate is generated independently from hj ∼ N (0, 1), j = 1, . . . , p.
These column vectors comprise the predictor matrix H.
The fourth factor relates to the specification of the treatment assignment mechanism
(Z-model) as linear or non-linear. We assume the Z-model follows a multinomial logit
model. Using the third treatment group as the reference group, the general form is Z ∼
Multinomial(n, p1, p2, p3) with p1 = ex1/(1 + ex1 + ex2), p2 = ex2/(1 + ex1 + ex2), p3 =
1/(1 + ex1 + ex2), ex1 = exp(α1 + Hξ
L
1 + Qξ
NL
1 ) and ex2 = exp(α2 + Hξ
L
2 + Qβ
NL
2 ), where
offsets α1 and α2 are specified to create the appropriate ratio of units in three treatment
groups, and Q denotes the nonlinear transformations and higher-order terms of the covariates
in H. We consider that the log-odds, log(p1/p3) and log(p2/p3), are linear or nonlinear in the
covariates. The nonlinear form of this assignment mechanism includes only the Q matrix
and its corresponding nonzero coefficients ξNL.
The fifth factor varies the relative importance of the covariates with regard to the as-
signment mechanism versus the response surface. In one setting of this factor, “aligned”,
there is substantial alignment in the predictive strength of the covariates across these two
mechanisms. In this setting, the covariates that best predict the treatment also predict the
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outcome well. In the other setting, “not as aligned”, the covariates that best predict the
treatment and those that best predict the response are less aligned. The sixth factor is
whether or not the response surfaces are parallel across treatment groups.
We simulate two sets of response surfaces that differ in both their level of alignment with
the assignment mechanism and whether they are parallel or not. Both sets are nonlinear in
the covariates and each set is generated generally as
E[Y (1)|H] = Pr[Y (1) = 1|H] = logit−1{HγL1 + QγNL1 }/5,
E[Y (2)|H] = Pr[Y (2) = 1|H] = logit−1{HγL2 + QγNL2 }/5 + τ,
E[Y (3)|H] = Pr[Y (3) = 1|H] = logit−1{HγL3 + QγNL3 }/5 + 2τ,
(14)
where γLt is a vector of coefficients for the untransformed versions of the predictors H and γ
NL
t
is a vector of coefficients for the transformed versions of the predictors captured in Q. In the
scenarios with parallel response surfaces, τ is 0.05, γL1 = γ
L
2 = γ
L
3 and γ
NL
1 = γ
NL
2 = γ
NL
3 and
both use the coefficients from Y (1). In the scenarios with response surfaces are not parallel,
τ = 0, the nonzero coefficients in the γLt and γ
NL
t are selected as different. Table 1 illustrates
the alignment in predictor strength between the assignment mechanism and response surfaces
for each of the two scenarios.
We replicate each of the 96 scenarios 200 times, and in each replication, we implement
each of four estimation methods, including RA, IPTW (using normalized weights), vector
matching, and BART. We use the bart() function in the BART package in the R Statistical
Software to fit BART models. For each BART fit, we allow the maximum number of trees
in the sum to be 100. To ensure the convergence of the MCMC in BART without having
to check for each simulation run, we are conservative and let the algorithm run for 3,500
iterations with the first 500 considered burn-in. The Bayesian logistic regression model
is implemented using the bayesglm() function in the arm package in R. To ensure a fair
comparison (e.g., that resulting inference generalizes to the same population), we employ
naive implementations of VM and IPTW. That is, patients falling outside the overlap area
determined by VM are not discarded and IPTW weights are not trimmed.
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Table 1: Nonzero coefficients in ξL and ξNL for the Z-model as well as in γL and γNL for the nonparallel response surfaces. Coefficients
for the parallel response surface are the same as those for Y (1) in the nonparallel response surface.
x1 x2 x3 x
2
1 x
2
2 x
2
3 x4 x5 x6 x
2
4 x
2
5 x3x6 x4x6 x5x6 x7 x8 x9 x
2
7 x
2
8 x
3
9 x1x7 x2x8 x3x9 x7x8x9
Z-model
Linear
ex1 0.5 0.7 0.5 0.8 0.2 0.8
ex2 0.9 0.3 0.9 0.2 0.6 0.2
Nonlinear
ex1 0.5 1 2 0.2 0.5 1 0.6 1.2 1.5 1 0.6 0.4 0.5 0.7 0.9 0.5
ex2 2 1 0.5 1 0.5 0.2 1.5 0.6 1.2 0.7 1.2 0.6 0.9 0.7 0.5 0.5
Y -model
Aligned
Y (1) 0.8 0.6 0.8 0.5 0.7 0.9 0.6
Y (2) 0.4 0.8 1 0.3 0.3 1.2 0.6
Y (3) 0.6 0.4 1 0.5 0.5 1 0.6
Not aligned
Y (1) 0.8 0.6 0.8 0.8 0.7 1.2 0.5 0.5 0.2
Y (2) 0.4 0.8 1 0.6 0.5 1 0.5 1.2
Y (3) 0.6 0.4 1 0.8 1.0 1.2 1.0
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5.2 Simulation Results
Figure 1 shows average bias and RMSE across each of the 200 simulations at each configura-
tion for each of three methods: Matching, IPTW, and BART. We do not show RA given its
overall poor performance: across all configurations and simulations, the average bias using
RA was -0.123 and the average RMSE was 0.129, each of which rate well below the other
three methods. The average bias and RMSE across all configurations are shown in Figure 1
using dotted vertical (average RMSE) and horizontal (average bias) lines.
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Figure 1: Average bias and RMSE among 200 simulations at each of 96 configurations for
each of three methods and two treatment effects. Dotted lines reflect averages (bias and
RMSE) taken across the configuration factors. In general, BART shows lowest RMSE and
relatively low bias compared to vector matching (Matching) and inverse probability weighting
(IPTW) for both treatment effects. IPTW consistently yields the highest RMSE.
For both treatment effects, BART offers a substantially better performance as judged
using RMSE. More than 50% of configuration factors for Matching and IPTW average an
RMSE greater than 0.05, compared to 10% for BART. Along the same lines, no BART
configuration averages an RMSE greater than 0.10, compared to 14% of configuration factors
for each of Matching and IPTW. In eight configurations (4%), IPTW averages an RMSE
grater than 0.15.
Results are mixed when judging each method using the average bias across simulations.
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For comparing treatment 2 versus 1, all three methods perform admirably, with none yielding
an average bias greater than 0.04 in absolute value. For comparing treatment 3 versus 1,
each of BART, IPTW, and Matching have certain settings in which they perform well and
others in which they yield a large average bias.
We next rank each configuration factor by which provide the largest influence on the bias
of each simulation, as in Rubin (1979), Cangul et al. (2009), and Lopez et al. (2017). The top-
6 factors for each approach are shown in Table 2. The treatment assignment model explains
the largest faction of variability for both Matching (17%) and IPTW (22%), but is not a
prominent factor for BART. This follows our intuition given that BART is the only approach
does not require the specification of a treatment assignment model. The interaction between
response surface (Y -model) and which treatment effect is being estimated (abbreviated in
the table as ATT), as well as the number of covariates p, rank as the most important factors
for BART (23% of variability apiece). The alignment of the treatment and response surfaces
is not a major factor for any of the three approaches; the ratio of treated to non-treated
units ranks as the fifth-most important factor for BART.
Table 2: Ranking of each configuration factor (including two-way interaction terms) with
respect to the amount of variance in bias explained by each. The treatment model factor
(Z-model) explains the largest amount of variability in performance for matching and IPTW,
while the interaction of treatment effect and the outcome model (Y -model) ranks first for
BART.
Matching IPTW BART
Term % explained Term % explained Term % explained
Z-model 0.17 Z-model 0.22 Y -model:ATT 0.23
ATT 0.16 Z-model:Y -model 0.16 p 0.23
Y -model 0.15 Y -model 0.14 Y -model 0.17
Z-model:Y -model 0.14 ATT 0.09 ATT:p 0.06
Z-model:ATT 0.06 Z-model:ATT 0.07 ratio 0.03
Y -model:ATT 0.03 Y -model:ATT 0.03 Z-model:Aligned 0.03
The configuration factors most impacting bias are the Z-model, Y -model, p, and ATT .
To further detail the effects of these principal determinants, Figure 2 shows boxplots of
bias based on different Z-model’s, Y -model’s, p’s, and ATT ’s for each method using all
simulations. Note that to better detail the performance of each approach, we bound absolute
bias by 0.25; this loses 1.1% of all IPTW simulations and 0.6% of all Matching simulations
which lie beyond this cutoff. For estimating the effect of treatment 2 versus 1, BART tends
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Figure 2: Bias at each simulation, separated by critical configuration factors (10 or 50
covariates, linear or non-linear treatment model, parallel or non-parallel response surface,
treatment effect 2 v.1/3 v. 1). BART generally performs better for treatment effect 2 v. 1
and with fewer covariates. IPTW and Matching tend to perform poorly when the treatment
assignment model is non-linear.
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to offer bias closest to 0. The median bias for BART for this treatment effect is almost always
0, with the exception of when there are p = 50 covariates, a non-linear Z-model, and a non-
parallel Y -model. Matching likewise boasts an average bias near 0 for most configuration
settings shown. IPTW tends to show larger bias when the treatment assignment model is
non-linear.
For estimating the effect of treatment 3 versus 1, BART tends to do worse with increased
numbers of covariates. However, in many of the settings where BART is off, including p = 50,
a non-linear Z-model, and a parallel Y -model, IPTW and Matching are likewise off. Given
that BART also avoids large absolute bias’, it is reasonable to argue that BART matches or
exceeds IPTW and Matching in all configurations.
6 Application to SEER-Medicare Data on NSCLC
We use a large-scale population-based database, drawn from the latest SEER-Medicare link-
age, to compare the effectiveness of three surgical approaches – robotic-assisted surgery,
VATS or open thoractomy. This dataset includes stage I-IIIA NSCLC patients above 65
years of age who were diagnosed between 2008 and 2013 and treated with either of the three
operative approaches.
Of the 11,980 total patients, 396 (3.3%) received robotic-assisted surgery, 6582 (54.9%)
underwent VATS, and the remaining 5002 (41.8%) were operated with open thoracotomy.
Pretreatment patient characteristics include age, gender, marital status, race, income level,
comorbidities, year of diagnosis, cancer stage, tumor size, tumor site, cancer histology and
staging work-up tests (e.g., positron emission tomography (PET), chest computer tomog-
raphy (CT), mediastinoscopy). Table 3 summarizes these variables for each surgery group.
Compared to VATS, patients receiving robotic-assisted surgery are less likely to be white
(80.8% vs. 86.5%), tend to have higher incomes (28.5% vs. 20.9% in highest quartile), more
likely to be in stage I (74.5% vs. 63.7%) and have smaller tumor size (40.4% vs. 29.8% in
≤ 20mm). Compared to open thoracotomy, patients undergoing robotic-assisted surgery are
less likely to be white (80.8% vs. 87.3%), and more likely to have staging work-up tests (PET
scan: 76.3% vs. 68.2%; chest CT: 66.4% vs. 62.9%; mediastinoscopy: 15.7% vs. 8.4%).
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Figure 3 displays density plots for the estimated probabilities of receiving each of the
three surgical procedures (x-axis), presented separately for each cohort of patients (y-axis).
These treatment assignment probabilities are estimated using a multinomial logistic regres-
sion model with patient baseline characteristics (shown in Table 3) as main effects. For each
treatment, given preoperative patient characteristics available, patients are more likely to
receive the surgical procedures that are actually received. However, there is a relatively de-
cent amount of overlap in the distributions of generalized propensity scores among patients
across different treatment groups.
Figure 3: Estimated probability of receiving each treatment (generalized propensity score,
or GPS), as calculated using multinomial logistic regression. Probabilities pertaining to the
the treatment actually observed for each patient are highlighted.
We implement VM and BART in our comparative effectiveness analysis. For VM, we
used a combination of k-means clustering with k = 5 subclasses and one-to-one matching
with replacement and a caliper of 0.25 to ensure that the matched cohort is relatively similar
in terms of the distributions of observed patient baseline characteristics. Applying BART
to the empirical dataset, we used the default priors associated with the bart() function
available in the BART package in R. For each BART fit, we allowed the maximum number
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of trees in the sum to be 100. To ensure the convergence of the MCMC in BART, we let
the algorithm run for 5,000 iterations with the first 1,000 considered as burn-in. We further
explore the sensitivity of BART for binary outcomes to the choice of end-node prior, specif-
ically via the hyperparameter k (Dorie et al., 2016). We employed 5-fold cross-validation to
choose the optimal k that minimizes the misclassification error. Results suggest the optimal
hyperparameter is the default k in bart(). Additionally, we extended the 1 sd rule, one of
the BART discarding rules proposed by Hill and Su (2013), to the multiple treatment setting
to assess whether overlap is reasonable based on the uncertainty in the posterior predictive
distributions associated with the outcome in the observed versus the counter-factual treat-
ment group. We did not exclude any patients from the empirical dataset based on the 1 sd
rule.
Table 4 presents the point and interval estimates of ATTs1|s1,s2 (robotic-assisted surgery
vs. open thoracotomy) and ATTs1|s1,s3 (robotic-assisted surgery vs. VATS). BART and VM
yield similar point estimates and variation associated with treatment effect on respiratory
complication. Both methods report a statistically insignificant effect on respiratory compli-
cation rate if patients who received robotic-assisted surgery had instead been treated with
open thoracotomy or VATS. There is insufficient evidence that robotic-assisted surgery has
a protective or adverse effect on respiratory complication, among those who were operated
with the robotic-assisted technology, compared to open resection or VATS.
7 Concluding Remarks
In this paper, we adapt BART, a nonparametric Bayesian modeling technique, into causal
inference under the complex settings of multiple treatments and a binary outcome. We in-
vestigated the performance of BART in a large number of scenarios varying across six design
factors including the response surfaces, treatment assignment mechanism, level of confound-
ing, sample sizes, ratio of units and the number of predictors. Simulations consistently
demonstrated that BART has a superior performance with smaller bias and RMSE across
the scenarios that were examined, compared to existing methods for multiple treatments. In
addition, BART is able to generate coherent interval estimates of the treatment effects. This
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is particularly useful for a binary outcome wherein different causal estimands such as RD,
RR or OR, may be of interest, and in situations where inference about the causal estimators
(e.g., matching estimators) is difficult to generate.
We applied the proposed method to 11,980 stage I-IIIA NSCLC patients, drawn from
the latest SEER-Medicare linkage. There is insufficient evidence to establish that robotic-
assisted surgery has a protective or adverse effect on respiratory complication, among those
who were operated using the robotic-assisted technology, relative to open thoracotomy or
VATS.
The common support assumption is a key component in causal inference; however, iden-
tifying whether this assumption holds is an empirical question. Propensity score matching
methods (including VM) generally discard units that fall out of a range of estimated propen-
sity scores. BART provides a propensity score free strategy that avoids ambiguity with
respect to assessing covariate balance. To address concerns about the potential extrapola-
tion of BART, remedies such as 1 sd rule has been proposed to examine lack of common
support (Hill and Su, 2013). In our simulation study, to ensure an apples-to-apples compar-
ison, each method was implemented without discarding units, and therefore the inferences
applied to the same target population.
The influx of large-scale health datasets provide abundant opportunities for more in-depth
comparative effectiveness research. The promising performance of BART in the complex mul-
tiple treatment settings will lay groundwork for several future research avenues. First, the
flexibility offered by nonparametric modeling of BART can be leveraged to model regression
relationships in survival data. Second, individual treatment effects that are easily obtained
from BART provide a building block for estimating the heterogeneous treatment effect. Fi-
nally, we have made a significant untestable assumption related to unmeasured confounding.
Developing sensitivity analyses under this complex multiple treatments setting leveraging
BART would also be a worthwhile and important contribution.
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Table 3: Baseline characteristics of subjects receiving three surgical procedures in the SEER-
Medicare dataset.
Robotic-Assisted Surgery VATS Open Thoracotomy
Characteristics N = 396 N = 6582 N = 5002
Age (years), mean (SD) 74.3 (5.7) 73.9 (5.4) 74.5 (5.7)
Female, N (%) 223 (56.3) 3446 (52.4) 2941 (58.8)
Married, N (%) 227 (57.3) 3753 (57.0) 2802 (56.0)
Race, N (%)
White 320 (80.8) 5694 (86.5) 4369 (87.3)
Black 21 (5.3) 364 (5.5) 248 (5.0)
Hispanic 15 (3.8) 218 (3.3) 139 (2.8)
Other 40 (10.1) 306 (4.6) 246 (4.9)
Median household annual income, N (%)
1st quartile 97 (24.5) 2132 (32.4) 1009 (20.2)
2nd quartile 88 (22.2) 1729 (26.3) 1193 (23.9)
3rd quartile 98 (24.7) 1345 (20.4) 1143 (22.9)
4th quartile 113 (28.5) 1376 (20.9) 1657 (33.1)
Charlson comorbidity score, N (%)
0− 1 154 (38.9) 2163 (32.9) 1810 (36.2)
1− 2 113 (28.5) 1944 (29.5) 1379 (27.6)
> 2 129 (32.6) 2475 (37.6) 1813 (36.2)
Year of diagnosis, N (%)
2008-2009 14(3.5) 2686 (40.8) 1484 (29.7)
2010 33 (8.3) 1123 (17.1) 857 (17.1)
2011 85 (21.5) 1033 (15.7) 866 (17.3)
2012 131 (33.1) 899 (13.7) 821 (16.4)
2013 133 (33.6) 841 (12.8) 974 (19.5)
Cancer stage, N (%)
Stage I 295 (74.5) 4195 (63.7) 3884 (77.6)
Stage II 63 (15.9) 1504 (22.9) 709 (14.2)
Stage IIIA 38 (9.6) 883 (13.4) 409 (8.2)
Tumor size, in mm, N (%)
≤ 20 160 (40.4) 1967 (29.9) 2232 (44.6)
21− 30 98 (24.7) 1696 (25.8) 1388 (27.7)
31− 50 109 (27.5) 1804 (27.4) 987 (19.7)
≥ 51 29 (7.3) 1084 (16.5) 367 (7.3)
Histology, N (%)
Adenocarcinoma 255 (64.4) 3757 (57.1) 3348 (66.9)
Squamous cell carcinoma 107 (27.0) 2165 (32.9) 1167 (23.3)
Other histology 34 (8.6) 660 (10.0) 487 (9.7)
Tumor site, N (%)
Upper lobe 215 (54.3) 3829 (58.2) 2859 (57.2)
Middle lobe 27 (6.8) 308 (4.7) 335 (6.7)
Lower lobe 141 (35.6) 2195 (33.3) 1720 (34.4)
Other site 13 (3.3) 250 (3.8) 88 (1.8)
PET scan, N (%) 302 (76.3) 5004 (76.0) 3410 (68.2)
Chest CT, N (%) 263 (66.4) 4525 (68.7) 3148 (62.9)
Mediastinoscopy, N (%) 62 (15.7) 715 (10.9) 420 (8.4)
Abbreviations: SD = standard deviation; CT = computer tomography
Table 4: Estimated ATT (95% uncertainty intervals in parentheses) of surgical procedures
on respiratory complication using VM and BART.
Method ATTs1|s1,s2 ATTs1|s1,s3
VM −0.01(−0.07, 0.06) 0.01(−0.05, 0.07)
BART −0.02(−0.09, 0.06) 0.02(−0.06, 0.10)
29
